NVS

Cogent's New Stomach Cancer Treatment Cuts Progression Risk In Half, Gets Breakthrough Therapy Tag

01/26 11:06 am

Corticosteroids Market Report 2026 - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

01/26 05:51 am

Novartis Positions US Strategy As Defense Against Rising Trade Levies

01/23 11:57 am

Oncolytic Virotherapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

01/23 06:52 am

High Potency APIs Market Size to Reach USD 58.68 Billion by 2033, Driven by the Increasing Demand for Targeted and Oncology Therapies – SNS Insider

01/21 12:00 pm

Actionable Insights in the Dermatology Market: Navigating Technological Advances and Growth Trends

01/16 05:56 am

Generalized Myasthenia Gravis Market Outlook Shows Strong Momentum During the Forecast Period (2025–2034) Driven by Novel Immunotherapies | DelveInsight

01/14 02:00 pm

Systemic Lupus Erythematosus Market to Exhibit Growth at a CAGR of 9.4% During the Forecast Period (2025–2034) Owing to Rising Use of Biologics – Approvals of BENLYSTA and SAPHNELO, Plus a Strong Pipeline | DelveInsight

01/13 02:00 pm

Why Tempus AI Stock Rose Today

01/12 08:07 pm

3 Dividend Stocks to Buy in 2026 and Hold Forever

01/11 05:30 am

Accenture To Acquire UK AI Firm Faculty To Scale Enterprise AI

01/06 09:48 am

What's Going On With Royalty Pharma Stock Wednesday?

12/31 11:47 am

Drugmakers Plan Fresh Price Hikes On 350 Medicines In 2026

12/31 09:59 am

2 Top Stocks to Buy and Hold for the Long Term

12/22 03:30 am

Novartis and US government reach agreement on lowering drug prices in the US

12/19 03:30 pm

White House Readies Drug Price Deals With AbbVie, Novartis, Roche

12/18 11:14 am

Immuno-oncology Clinical Trials Market Projected to Reach USD 23.63 Billion by 2032 at a CAGR of 12.37% - SNS Insider

12/14 09:32 am

Roche's Oral Breast Cancer Drug Shows 30% Drop In Recurrence In Patients With Early Disease

12/11 01:27 pm

Novartis' Investigational Drug Reports Longer Disease Control In Patients With Rare Blood Disorder

12/09 03:32 pm

Ophthalmic Drugs Market Size to Cross USD 62.74 Billion by 2032, Driven by Advances in Eye Care Treatments and Rising Global Vision Disorders - SNS Insider

12/07 09:05 am

Is Alnylam Pharmaceuticals a Millionaire Maker?

12/07 03:25 am

CAR T-Cell Therapy Market Industry Trends and Global Forecasts to 2035 by Target Antigens, Target Indication, Key Geographies, Sales Forecast of Drugs and Leading Players

12/05 06:41 am

Europe Behavioral Health Market Size to Capture USD 63.23 Billion by 2034

11/28 12:00 pm

U.S. CAR T-Cell Therapies Market Grows at 30.4% CAGR, Soars USD 42.61 Billion by 2035

11/27 12:00 pm

Why Novartis Stock Topped the Market Today

11/25 08:17 pm

FDA OKs Novartis SMA Treatment As First Gene Therapy Option For Kids, Teens And Adults

11/25 11:14 am

Novartis data underscore pioneering scientific innovation in Hematology and Oncology at ASH and SABCS

11/25 02:15 am

Muscular Dystrophy Association Calls FDA Approval of Novartis’ Itvisma (onasemnogene abeparvovec-brve) a Major Step Forward for the Spinal Muscular Atrophy Community

11/24 11:21 pm

ThinkCareBelieve: Week 44 Trump Presidency Making the American Dream Possible

11/22 02:58 pm

Biotechnology CMO and CDMO Market on Track for USD 199.67 Billion by 2034 with a Strong 11.54% CAGR

11/21 11:00 am

Novartis Projects Faster Growth Through 2030 After Raising Drug Forecasts

11/20 01:43 pm

Hospital Care Collaboration and Licensing Agreements Analysis Report and Directory 2025: Upfront, Milestone, and Royalties for 726 Deals by Company A-Z, Therapy Focus and Technology Type

11/19 11:59 am

Trump Unveils $200 Billion Trade Deal With Switzerland And Liechtenstein To Cull $38.5 Billion US Goods Deficit By 2028

11/15 03:05 am

Novartis Phase III trial for next-generation malaria treatment KLU156 (GanLum) meets primary endpoint, with potential to combat antimalarial resistance

11/12 06:00 pm

Food Allergy Market Valued at USD 3 Billion across the 7MM, Projected to Grow at CAGR of 11.3% by 2034 | DelveInsight

11/10 02:00 pm

Orphan Drug Market to Reach USD 621.85 Billion by 2034, Driven by Rising Rare Disease Incidence and Innovation

11/10 12:00 pm

High Concentration mAb Products Market Advancing Precision Biopharmaceutical Therapeutics – Towards Healthcare

11/06 12:00 pm

Choroidal Neovascularization Market to Witness Accelerated Growth Throughout the Forecast Period (2025–2034) Due to Advancement in Anti-VEGF Therapies | DelveInsight

11/05 02:00 pm

New Novartis data at ASN Kidney Week and AHA Scientific Sessions demonstrate momentum of broad CRM portfolio and pipeline

11/04 02:15 am

The Heart-Body Connection: How Other Organ Systems Affect Heart Health

11/03 03:35 pm

Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences

11/03 08:00 am

Pharmaceutical Market to Reach USD 3,033.21 Billion by 2034 Driven by Rising Geriatric Population

10/29 11:00 am

Novartis Maintains Outlook Even As Generics Bite Into Profits

10/28 06:58 am

Why Dyne Therapeutics Stock Crushed the Market on Monday

10/27 06:17 pm

Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology

10/27 08:30 am

Avidity Shareholders Win Big As Novartis Moves Fast On $12 Billion Deal

10/27 06:11 am

Stock Market Today: Dow Jones, S&P 500 Futures Climb Ahead Of Busy Week On Wall Street—Novartis, Nucor, Waste Management In Focus

10/27 06:02 am

RNA STOCK ALERT: HALPER SADEH LLC IS INVESTIGATING WHETHER THE SALE OF AVIDITY BIOSCIENCES, INC. IS FAIR TO SHAREHOLDERS

10/26 06:36 pm

Novartis agrees to acquire Avidity Biosciences, an innovator in RNA therapeutics, strengthening its late-stage neuroscience pipeline

10/26 01:00 pm

Monte Rosa Therapeutics Presents Preclinical Data at ACR Convergence 2025 on the Potential of MRT-6160, a VAV1-directed Molecular Glue Degrader, to Treat Immune-mediated Diseases

10/24 07:00 am